This inventor holds 1 USPTO granted patent. Top assignee: Kineta, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: David Scott Johnson and His Work on VISTA Antibodies.
Introduction
David Scott Johnson is an inventor associated with South San Francisco, California, and Kineta, Inc. His patent work concerns antibodies targeting V-domain Ig-containing Suppressor of T cell Activation (VISTA), an area of research with potential applications in cancer treatment.
Latest Patents
Johnson is named on one patent: “Anti-vista antibodies and uses thereof.” The disclosure describes antibodies that bind specifically to VISTA, compositions containing those antibodies, and methods for using them to treat diseases, including cancer. The patent count provided for Johnson is 1 patent.
Career Highlights
Johnson’s listed invention reflects Kineta’s work in therapeutic research, particularly the development of antibody-based approaches to disease treatment. The patent describes potential uses of VISTA-targeting antibodies but does not, by itself, establish clinical effectiveness or approval.
Collaborations
Johnson’s listed coworkers include Shawn P. Iadonato and Thierry Guillaudeux. Their names provide context for the professional network associated with his work.
Conclusion
David Scott Johnson’s patent on anti-VISTA antibodies documents an invention focused on potential therapeutic applications, including cancer treatment, and connects his work with Kineta, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile